[Use of nebulizer in berodual treatment of patients with chronic obstructive bronchitis in exacerbation].
OBJECTIVE
To study efficiency and safety of berodual in solution for inhalations delivered with the help of nebulizer in patients with exacerbation of chronic bronchitis (CB).


METHODS
12 patients with chronic bronchitis who had not responded to oral methylxantines in combination with expectorants received berodual for 10 days (1 ml 3 times a day).


RESULTS
In the course of berodual treatment all the CB symptoms relieved and external respiration function improved.


CONCLUSIONS
Berodual is effective as monotherapy of chronic obstructive bronchitis.
Shmelev
E I
EI
Khmel'kova
N G
NG
Abubikirov
A F
AF
D000280:Administration, Inhalation; D000328:Adult; D000336:Aerosols; D001991:Bronchitis / Q000188:drug therapy* / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D002908:Chronic Disease; D004338:Drug Combinations; D005260:Female; D005280:Fenoterol / Q000008:administration & dosage*; D006801:Humans; D009241:Ipratropium / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009330:Nebulizers and Vaporizers; D012008:Recurrence; D012129:Respiratory Function Tests; D016896:Treatment Outcome
D000336:Aerosols; D001993:Bronchodilator Agents; D004338:Drug Combinations; C030809:fenoterol, ipratropium drug combination; D005280:Fenoterol; D009241:Ipratropium